Literature DB >> 16574404

Association between diabetes mellitus and adverse characteristics of breast cancer at presentation.

Ido Wolf1, Siegal Sadetzki, Iris Gluck, Bernice Oberman, Merav Ben-David, Moshe Zvi Papa, Raphael Catane, Bella Kaufman.   

Abstract

Type 2 diabetes mellitus is associated with increased incidence and inferior outcome of various malignancies. The aim of this study was to explore the impact of type 2 diabetes on breast cancer characteristics at presentation. The study population included 79 diabetic and 158 age-matched non-diabetic patients. Parity, country of birth, co-morbidity other than diabetes, and mode of diagnosis were similar in both groups. Mean body mass index (BMI) was higher among diabetic patients. Tumour stage and size were higher among diabetic patients and the differences remained significant after adjustment for BMI. Moreover, after adjustment for BMI, breast cancer among diabetic patients was more often hormone receptor negative. Our results show that diabetes mellitus is associated with negative prognostic factors at breast cancer presentation.

Entities:  

Mesh:

Year:  2006        PMID: 16574404     DOI: 10.1016/j.ejca.2006.01.027

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Prognosis of small cell lung cancer patients with diabetes treated with metformin.

Authors:  T Xu; G Liang; L Yang; F Zhang
Journal:  Clin Transl Oncol       Date:  2015-06-11       Impact factor: 3.405

3.  Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells.

Authors:  Güzin Fidan-Yaylalı; Yavuz Dodurga; Mücahit Seçme; Levent Elmas
Journal:  Tumour Biol       Date:  2015-09-24

4.  Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Authors:  Soley Bayraktar; Leonel F Hernadez-Aya; Xiudong Lei; Funda Meric-Bernstam; Jennifer K Litton; Limin Hsu; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

Review 5.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

6.  Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes.

Authors:  Guixiang Zhao; Earl S Ford; Indu B Ahluwalia; Chaoyang Li; Ali H Mokdad
Journal:  J Gen Intern Med       Date:  2008-12-17       Impact factor: 5.128

7.  Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study.

Authors:  Thomas I Barron; Evelyn M Flahavan; Linda Sharp; Kathleen Bennett; Kala Visvanathan
Journal:  Cancer Res       Date:  2014-08-01       Impact factor: 12.701

8.  Obesity and angiolymphatic invasion in primary breast cancer.

Authors:  Erin F Gillespie; Melony E Sorbero; David A Hanauer; Michael S Sabel; Emily J Herrmann; Laura J Weiser; Christina H Jagielski; Jennifer J Griggs
Journal:  Ann Surg Oncol       Date:  2009-11-07       Impact factor: 5.344

9.  The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.

Authors:  Susan A Sabatino; Trevor D Thompson; Xiao-Cheng Wu; Steven T Fleming; Gretchen G Kimmick; Amy Trentham-Dietz; Rosemary Cress; Roger T Anderson
Journal:  Breast Cancer Res Treat       Date:  2014-06-05       Impact factor: 4.872

10.  Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006.

Authors:  C-H Tseng; C-K Chong; T-Y Tai
Journal:  Diabetologia       Date:  2008-11-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.